RU99118680A - NEW AMIDA DERIVATIVES AND THEIR MEDICINAL COMPOSITIONS - Google Patents

NEW AMIDA DERIVATIVES AND THEIR MEDICINAL COMPOSITIONS

Info

Publication number
RU99118680A
RU99118680A RU99118680/04A RU99118680A RU99118680A RU 99118680 A RU99118680 A RU 99118680A RU 99118680/04 A RU99118680/04 A RU 99118680/04A RU 99118680 A RU99118680 A RU 99118680A RU 99118680 A RU99118680 A RU 99118680A
Authority
RU
Russia
Prior art keywords
optionally substituted
lower alkyl
acetanilide
phenoxypropyl
hydroxy
Prior art date
Application number
RU99118680/04A
Other languages
Russian (ru)
Other versions
RU2191177C2 (en
Inventor
Татсуя МАРУЯМА
Кенити Онда
Масахико Хаякава
Такуми ТАКАХАСИ
Такаюки Сузуки
Тетсуо МАТСУИ
Original Assignee
Яманоути Фармасьютикал Ко.,Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Яманоути Фармасьютикал Ко.,Лтд filed Critical Яманоути Фармасьютикал Ко.,Лтд
Publication of RU99118680A publication Critical patent/RU99118680A/en
Application granted granted Critical
Publication of RU2191177C2 publication Critical patent/RU2191177C2/en

Links

Claims (6)

1. Амидное производное общей формулы (I) или его соль:
Figure 00000001

где А означает гетероарилен;
Х означает связь, О, S, -NR5-, -NR5CO-, -NR5CONH-, -NR5SO2- или -NR5C(= NH)NH-;
R1 означает H, необязательно замещенный низший алкил, необязательно замещенный арил, необязательно замещенный гетероарил или необязательно замещенный циклоалкил;
R2a, R2b означают H или низший алкил, которые могут быть одинаковыми или различными;
R3 означает водород или низший алкил;
R4a, R4b означают Н или ОН и могут быть одинаковыми или различными, или R4a и R4b вместе образуют группы =O или =N~O-низший алкил;
R5 означают Н или низший алкил.
1. Amide derivative of General formula (I) or its salt:
Figure 00000001

where a means heteroaryl;
X means a bond, O, S, -NR 5 -, -NR 5 CO-, -NR 5 CONH-, -NR 5 SO 2 - or -NR 5 C (= NH) NH-;
R 1 is H, optionally substituted lower alkyl, optionally substituted aryl, optionally substituted heteroaryl, or optionally substituted cycloalkyl;
R 2a , R 2b means H or lower alkyl, which may be the same or different;
R 3 is hydrogen or lower alkyl;
R 4a , R 4b means H or OH and may be the same or different, or R 4a and R 4b together form = O or = N ~ O-lower alkyl;
R 5 means H or lower alkyl.
2. Амидное производное или его соль по п. 1, где А представляет тиазолилен, имидазолилен, триазолилен, бензимидазолилен, бензотиазолилен, тиадиазолилен, имидазопиридилен или имидазотиазолилен, и X означает связь, О, S, или -NR5-.2. The amide derivative or a salt thereof according to claim 1, wherein A represents thiazolylene, imidazolylene, triazolylene, benzimidazolylene, benzothiazolylene, thiadiazolylene, imidazopyridylene or imidazothiazolylene, and X is a bond, O, S, or -NR 5 -. 3. Амидное производное или его соль по п. 2, где А означает тиазолилен или имидазолилен, Х означает -NR5-; и R1 означает низший алкил, который замещен необязательно замещенным арилом, или необязательно замещенный арил.3. The amide derivative or its salt according to claim 2, wherein A is thiazolylene or imidazolylene, X is —NR 5 -; and R 1 is lower alkyl, which is substituted with an optionally substituted aryl, or an optionally substituted aryl. 4. (S)-2-(2-Бензиламино-4-тиазол-4-ил)-4'-[2-[(2-гидрокси-3-феноксипропил)амино] этил] ацетанилид; (S)-2-[2-(3-фтороанилино)-4-тиазол-4-ил)-4'-[2-[(2-гидрокси-3-феноксипропил) амино] этил]ацетанилид; (S)-2-(2-анилино-4-тиазол-4-ил)-4'-{2-[(2-гидрокси-3-феноксипропил)амино]пропил}ацетанилид; и (S)-2-(2-анилинотиазол-4-ил)-4'-{ 2-[(2-гидрокси-3-феноксипропил)амино]этил} ацетанилид и их соли. 4. (S) -2- (2-Benzylamino-4-thiazol-4-yl) -4 '- [2 - [(2-hydroxy-3-phenoxypropyl) amino] ethyl] acetanilide; (S) -2- [2- (3-Fluoroanilino) -4-thiazol-4-yl) -4 '- [2 - [(2-hydroxy-3-phenoxypropyl) amino] ethyl] acetanilide; (S) -2- (2-anilino-4-thiazol-4-yl) -4 '- {2 - [(2-hydroxy-3-phenoxypropyl) amino] propyl} acetanilide; and (S) -2- (2-anilinothiazol-4-yl) -4 '- {2 - [(2-hydroxy-3-phenoxypropyl) amino] ethyl} acetanilide and their salts. 5. Фармацевтическая композиция, содержащая амидное производное по п. 1 и его фармацевтически приемлемый носитель. 5. A pharmaceutical composition comprising the amide derivative according to claim 1 and a pharmaceutically acceptable carrier thereof. 6. Фармацевтическая композиция по п. 5 в качестве терапевтического средства для лечения сахарного диабета. 6. The pharmaceutical composition according to claim 5 as a therapeutic agent for the treatment of diabetes.
RU99118680/04A 1997-01-23 1998-01-22 Novel amide derivatives and pharmaceutical composition promoting insulin secretion and enhancing susceptibility to insulin RU2191177C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1036097 1997-01-23
JP9/10360 1997-01-23

Publications (2)

Publication Number Publication Date
RU99118680A true RU99118680A (en) 2001-05-27
RU2191177C2 RU2191177C2 (en) 2002-10-20

Family

ID=11748008

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99118680/04A RU2191177C2 (en) 1997-01-23 1998-01-22 Novel amide derivatives and pharmaceutical composition promoting insulin secretion and enhancing susceptibility to insulin

Country Status (17)

Country Link
US (2) US6048884A (en)
EP (1) EP0972769B1 (en)
KR (1) KR100519870B1 (en)
CN (1) CN1098841C (en)
AT (1) ATE237593T1 (en)
AU (1) AU729468B2 (en)
BR (1) BR9807506A (en)
CA (1) CA2272285C (en)
DE (1) DE69813539T2 (en)
ES (1) ES2191922T3 (en)
HU (1) HUP0000934A3 (en)
ID (1) ID21546A (en)
NO (1) NO312511B1 (en)
PL (1) PL334655A1 (en)
RU (1) RU2191177C2 (en)
TW (1) TW434234B (en)
WO (1) WO1998032742A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9462198A (en) 1997-10-17 1999-05-10 Yamanouchi Pharmaceutical Co., Ltd. Amide derivatives or salts thereof
PE20040804A1 (en) * 2002-12-19 2004-12-31 Boehringer Ingelheim Pharma CARBOXAMID DERIVATIVES AS INHIBITORS OF THE Xa FACTOR
CA2614098A1 (en) * 2005-07-04 2007-01-11 Dr. Reddy's Laboratories Ltd. Thiazoles derivatives as ampk activator
EP2334638B1 (en) * 2008-09-09 2018-11-21 F. Hoffmann-La Roche AG Polymorphs of acyl sulfonamides
CN103372020A (en) * 2013-07-04 2013-10-30 丁圣雨 Application of Chukrasone A in preparation of medicines for promoting insulin secretion
EP3717465A1 (en) 2017-11-30 2020-10-07 Step Pharma S.A.S. Compounds
US11655246B2 (en) * 2017-11-30 2023-05-23 Step Pharma S.A.S. Aminothiazole compounds as inhibitors of CTPS1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists

Similar Documents

Publication Publication Date Title
RU99105567A (en) PROPIONIC ACID DERIVATIVES AND THEIR USE
RU97118591A (en) DERIVATIVES OF ACETAMIDE, METHOD FOR ITS PREPARATION AND CONTAINING ITS PHARMACEUTICAL COMPOSITIONS
RU2003101319A (en) PHARMACEUTICAL COMPOSITION HAVING AN IMPROVED ANTITUMOR ACTION AND / OR REDUCED SIDE EFFECTS CONTAINING AN ANTITUMOR AGENT AND A DERIVATIVE HYDROGEN
LU90956I2 (en) Metvix active ingredient methylaminolevulinic in the form of a salt preferably methylaminolevulinic hydrochloride
PT1227806E (en) PHARMACEUTICAL FORMULA CONTAINING TOLTERODINE AND ITS UTILIZATION
ATE98651T1 (en) PEPTIDES WITH TACHYKIN ANTAGONIST ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
DK555089D0 (en) PHARMACEUTICAL PREPARATIONS CONTAINING N- (3,4-DIMETHOXYCINNAMOYL) ANTHRANIC ACID
RU2000102359A (en) PHARMACEUTICAL COMPOSITION HAVING AN IMPROVED ANTI-CANCER ACTION AND / OR REDUCED SIDE EFFECTS CONTAINING ANTI-CANCER AGENT AND HYDROXAMIC DERIVATIVE DERIVATIVE
ES2070994T3 (en) DOPAMINE PROFARMACO.
RU99118680A (en) NEW AMIDA DERIVATIVES AND THEIR MEDICINAL COMPOSITIONS
KR900007790A (en) Anti-Athemic Atherosclerotic Diaryl Compounds
NO172049C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SALPETIC ACID ESTERATE DERIVATIVES
PT82480A (en) Process for the preparation of 2-amino thiazoles n-substituted and for the corresponding pharmaceutical compositions
RU99121654A (en) MEANS FOR THE PREVENTION OR TREATMENT OF DISEASES ASSOCIATED WITH EXTREME PROLIFERATION OF EPITHELIAL PIGMENTAL RETAIN CELLS
SE8503055D0 (en) PIPERONYLCARBOXAMIDO DERIVATIVES
RU98103388A (en) (R) -5-BROM-N- (1-ETHYL-4-Methylhexagidro-1H-1,4-Diazepin-6-IL) -2-METHOXI-6-M COMPOSITION CONTAINING THE SPECIFIED CONNECTION
RU96103685A (en) 1,2,5-TIADIAZOLIC DERIVATIVES OF INDOLALALKYL-PYRIDINIL-PYRIMIDINIL-PIPERAZINES, METHOD OF TREATMENT OR PREVENTION OF THE DEVELOPMENT OF VASCULAR HEADACHE AND PHARMACEUTICAL COMPOSITION
KR930017887A (en) Pharmaceutical compound
JP2007516211A5 (en)
NO176018C (en) Analogous Process for Preparing Therapeutically Active S-Enantiomers of Substituted 2-Aminotetralins
CN111094259B (en) Analgesic compounds
RU99109978A (en) BIS (AKRIDINKARBOXAMID) and BIS (PHENASINCARBOXAMID), USEFUL AS ANTICOPODUS AGENTS
KR920006326A (en) New amino acid derivatives, a process for their preparation and pharmaceutical compositions containing them
SE9900190D0 (en) New compounds
WO2012012156A1 (en) Methods and compositions for the improvement of skeletal muscle function in a mammal